Paul Burton
Chief Tech/Sci/R&D Officer presso AMGEN INC.
Patrimonio netto: 101 658 $ in data 31/03/2024
Profilo
Il dott. Paul Burton è responsabile degli affari medici globali presso Janssen Pharmaceuticals, Inc. Il dottor Burton è stato precedentemente impiegato come vicepresidente presso Janssen Research & Development LLC. Si è laureato all'Università di Londra e ha conseguito un dottorato all'Imperial College di Londra.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
MODERNA, INC.
0.00% | 07/11/2022 | 954 ( 0.00% ) | 101 658 $ | 31/03/2024 |
Posizioni attive di Paul Burton
| Società | Posizione | Inizio |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01/06/2023 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Chief Tech/Sci/R&D Officer | 01/03/2020 |
| Royal College of Surgeons | Corporate Officer/Principal | - |
Precedenti posizioni note di Paul Burton
| Società | Posizione | Fine |
|---|---|---|
| MODERNA, INC. | Chief Tech/Sci/R&D Officer | 01/01/2023 |
| JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | - |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | - |
Formazione di Paul Burton
| Imperial College London | Doctorate Degree |
| University of London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| MODERNA, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
- Borsa valori
- Insiders
- Paul Burton
